Probuphine is a new drug recently developed and released by Braeburn Pharmaceuticals. The drug is FDA-approved and is a time-released version of buprenorphine (the active ingredient in Suboxone that staves off opioid withdrawal symtoms). Probuphine must be implanted beneath the patient’s skin (typically in the arm) where it gradually distributes medication for 6 months. The

ADS Board Member, Stacy Smith, recently notified ADS staff of a powerful documentary she viewed which just aired on PBS. The film is titled Chasing Heroin. It is an expertly produced piece on the resurgence of heroin addiction in America. Chasing Heroin profiles a number of individuals and families who are struggling with heroin/opioid addiction.

Methadone is the prescribed medication which ADS uses to assist opioid-addicted people in their effort to become free of heroin and other deadly opiates. Methadone has been proven a highly effective treatment intervention for individuals struggling with daily opioid withdrawal. Methadone is FDA-approved and is presently being prescribed to many thousands of opioid-addicted people throughout

The Metronews of Canada recently published an article outlining a recent increase in the utilization of methadone to treat opioid addiction. The Alberta Canada Health agency shared statistics showing that approximately twice as many people began opioid replacement therapy with methadone during the fiscal year 2012 – 2013. The number of patients receiving methadone rose

There is an interesting blog post by Dr. Jana Burson in which she discusses a recent study in the Journal of the American Medical Association (JAMA). The study occurred in the state of Connecticut, and it centered on providing patients a 3-day supply of buprenorphine when they presented in the ER and were found to

Alcohol and drug addiction most definitely take their toll … often for many consecutive years. A large number of people who currently suffer with addictive disease developed this illness gradually. However, there are the dramatic experiences variety in which someone becomes quickly addicted to a drug like heroin, cocaine, or methamphetamine after using only a

Local media have been increasing their coverage of the growing problem with opioid addiction in the Piedmont Triad community. In the article referenced here, Beating The Heroin Addiction, WFMY provide a news piece addressing the fact that 11 people in High Point have died of a heroin overdose since March and an additional 94 individuals

WXII 12 have posted a news item on the Greensboro Police Department’s decision to train 235 officers in the administration of naloxone (often known by the brand name, Narcan). Naloxone reverses the potentially deadly effects of opioid overdose and can restore breathing to overdose victims within minutes. This decision is in response to the rash

The Greensboro News and Record has provided an informative series on local opioid addiction, overdose reversal using naloxone, and addiction treatment. The online versions of these stories contain two videos: one that profiles the brave recovery journey of a young mother presently in ADS’ Opioid Treatment Program and another video in which Dr. Anthony Steele

Rhino Times has published an interesting article on the rise of heroin abuse in Guilford County. Writer Scott Yost details the rash of sudden overdoses that have plagued the area. In the piece, Scott interviews Jim Albright who is Director of the Guilford County Emergency Services. Albright points to April of 2014 as the month